Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1855 1
1893 1
1912 1
1945 1
1946 1
1947 1
1948 3
1950 1
1951 4
1954 2
1956 2
1957 4
1958 2
1960 1
1961 1
1963 3
1964 3
1965 7
1966 6
1967 3
1968 5
1969 4
1970 3
1971 4
1972 7
1973 9
1974 6
1975 10
1976 7
1977 13
1978 15
1979 5
1980 11
1981 5
1982 11
1983 8
1984 8
1985 15
1986 10
1987 9
1988 19
1989 33
1990 25
1991 20
1992 20
1993 16
1994 32
1995 10
1996 30
1997 59
1998 72
1999 84
2000 157
2001 158
2002 177
2003 268
2004 261
2005 248
2006 292
2007 284
2008 255
2009 261
2010 278
2011 298
2012 263
2013 246
2014 262
2015 315
2016 299
2017 248
2018 285
2019 270
2020 345
2021 359
2022 357
2023 406
2024 127

Text availability

Article attribute

Article type

Publication date

Search Results

6,633 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Hesstvedt
Page 1
SGN-LIV1A: a novel antibody-drug conjugate targeting LIV-1 for the treatment of metastatic breast cancer.
Sussman D, Smith LM, Anderson ME, Duniho S, Hunter JH, Kostner H, Miyamoto JB, Nesterova A, Westendorf L, Van Epps HA, Whiting N, Benjamin DR. Sussman D, et al. Mol Cancer Ther. 2014 Dec;13(12):2991-3000. doi: 10.1158/1535-7163.MCT-13-0896. Epub 2014 Sep 24. Mol Cancer Ther. 2014. PMID: 25253783
In this article, we describe a novel antibody-drug conjugate (ADC; SGN-LIV1A), targeting the zinc transporter LIV-1 (SLC39A6) for the treatment of metastatic breast cancer. LIV-1 was previously known to be expressed by estrogen receptor-positive breast cancers. ...I …
In this article, we describe a novel antibody-drug conjugate (ADC; SGN-LIV1A), targeting the zinc transporter LIV-1 (SLC39A6) for the …
The LIV-1 Subfamily of Zinc Transporters: From Origins to Present Day Discoveries.
Taylor KM. Taylor KM. Int J Mol Sci. 2023 Jan 9;24(2):1255. doi: 10.3390/ijms24021255. Int J Mol Sci. 2023. PMID: 36674777 Free PMC article. Review.
This review explains the origin of the LIV-1 family of zinc transporters, paying attention to how this family of nine human proteins was originally discovered. Structural and functional differences between these nine human LIV-1 family members and the five other ZIP …
This review explains the origin of the LIV-1 family of zinc transporters, paying attention to how this family of nine human proteins …
In memoriam Liv Hatle 1936-2023, pioneering echocardiologist.
Fraser AG, Sutherland GR, Bijnens B. Fraser AG, et al. Eur Heart J Cardiovasc Imaging. 2023 Aug 26;24(11):1425-9. doi: 10.1093/ehjci/jead206. Online ahead of print. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37633262 Free PMC article.
Professor Liv Hatle died in June 2023. In Trondheim, Norway, in the mid-1970s she was the first cardiologist to be given access to a PEDOF Doppler ultrasound system for clinical examinations, which she used to investigate cardiovascular haemodynamics non-invasively. ...
Professor Liv Hatle died in June 2023. In Trondheim, Norway, in the mid-1970s she was the first cardiologist to be given access to a …
Strategies to Avoid Distal Junctional Pathology.
Marciano GF, Simhon ME, Lehman RA, Lenke LG. Marciano GF, et al. Neurosurg Clin N Am. 2023 Oct;34(4):585-597. doi: 10.1016/j.nec.2023.06.006. Epub 2023 Aug 1. Neurosurg Clin N Am. 2023. PMID: 37718105 Review.
Much of the avoidant strategy relies on understanding the deformity pathology, selection of the lowest instrumented vertebra (LIV), health of the segments caudal to the LIV, and methods of fixation....
Much of the avoidant strategy relies on understanding the deformity pathology, selection of the lowest instrumented vertebra (LIV), h …
Roles of E-cadherin in Hepatocarcinogenesis.
Maeda S, Nakagawa H. Maeda S, et al. In: Nakao K, Minato N, Uemoto S, editors. Innovative Medicine: Basic Research and Development [Internet]. Tokyo: Springer; 2015. In: Nakao K, Minato N, Uemoto S, editors. Innovative Medicine: Basic Research and Development [Internet]. Tokyo: Springer; 2015. PMID: 29787164 Free Books & Documents. Review.
Microarray analysis showed that expression of stem cell markers such as CD44 and Sox9, and inflammatory cytokines such as IL-6 and TNF-alpha, are increased in Cdh1 (Liv ) liver compared with Cdh1 ( flox/flox ) liver. To investigate the role of E-cadherin in the liver tumor …
Microarray analysis showed that expression of stem cell markers such as CD44 and Sox9, and inflammatory cytokines such as IL-6 and TNF-alpha …
Ameliorative effects of Liv-52 on doxorubicin-induced oxidative damage in rat liver.
Yildirim N, Lale A, Yazıcı GN, Sunar M, Aktas M, Ozcicek A, Suleyman B, Ozcicek F, Suleyman H. Yildirim N, et al. Biotech Histochem. 2022 Nov;97(8):616-621. doi: 10.1080/10520295.2022.2065533. Epub 2022 May 9. Biotech Histochem. 2022. PMID: 35527648
Thirty male rats were assigned randomly into three equal groups: control (CG), Dox group (DG) Liv-52 + Dox group (LD). Rats in the LD group received 50 mg/kg Liv-52 in distilled water via gastric gavage. ...Therefore, pre-treatment with Liv-52 protected again …
Thirty male rats were assigned randomly into three equal groups: control (CG), Dox group (DG) Liv-52 + Dox group (LD). Rats in the LD …
Zinc and cancer: implications for LIV-1 in breast cancer.
Grattan BJ, Freake HC. Grattan BJ, et al. Nutrients. 2012 Jul;4(7):648-75. doi: 10.3390/nu4070648. Epub 2012 Jul 4. Nutrients. 2012. PMID: 22852056 Free PMC article. Review.
Despite evidence of its potential utility as a target gene for cancer prognosis and treatment, LIV-1 has received relatively little attention, with only three prior reviews being published on this topic. Herein, the physiological effects of zinc are reviewed in light of th …
Despite evidence of its potential utility as a target gene for cancer prognosis and treatment, LIV-1 has received relatively little a …
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer.
Taylor KM, Morgan HE, Smart K, Zahari NM, Pumford S, Ellis IO, Robertson JF, Nicholson RI. Taylor KM, et al. Mol Med. 2007 Jul-Aug;13(7-8):396-406. doi: 10.2119/2007-00040.Taylor. Mol Med. 2007. PMID: 17673939 Free PMC article. Review.
The LIV-1 subfamily of ZIP zinc transporters consists of nine human sequences that share considerable homology across transmembrane domains. Many of these sequences have been shown to transport zinc and/or other ions across cell membranes. Increasingly, studies have implic …
The LIV-1 subfamily of ZIP zinc transporters consists of nine human sequences that share considerable homology across transmembrane d …
JMM Profile: Louping ill virus.
Folly AJ, McElhinney LM, Johnson N. Folly AJ, et al. J Med Microbiol. 2022 May;71(5). doi: 10.1099/jmm.0.001502. J Med Microbiol. 2022. PMID: 35604835
Louping ill virus (LIV) is a single-stranded, positive-sense RNA virus within the genus Flavivirus that is transmitted to vertebrate hosts by bites from infected ticks, the arthropod vector. ...However, vaccines have been discontinued in recent years. Although rare, LIV
Louping ill virus (LIV) is a single-stranded, positive-sense RNA virus within the genus Flavivirus that is transmitted to vertebrate …
Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis.
Azeemuddin M, Rafiq M, Anturlikar SD, Sharath Kumar LM, Patki PS, Babu UV, Shyam R. Azeemuddin M, et al. J Tradit Complement Med. 2015 Jan 22;6(2):160-7. doi: 10.1016/j.jtcme.2014.12.002. eCollection 2016 Apr. J Tradit Complement Med. 2015. PMID: 27114939 Free PMC article.
The effect observed with Liv.52 extract was comparable to that of pioglitazone (4 mg/kg b.wt.), a standard drug that is useful in the management of NASH. ...The results obtained in the present set of experiments indicate that Liv.52 extract effectively reverses meta …
The effect observed with Liv.52 extract was comparable to that of pioglitazone (4 mg/kg b.wt.), a standard drug that is useful in the …
6,633 results